Stay updated on Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The study now lists two locations, including Parkland Health & Hospital System in Dallas, TX; this augments the previously listed single-location site.
    Difference
    0.4%
    Check dated 2026-02-18T04:52:05.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the government funding status notice and the previous Revision: v3.4.1 from the page.
    Difference
    0.4%
    Check dated 2026-02-11T03:10:59.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Page now shows a government funding lapse notice with the NIH Clinical Center's operating status. The revision label has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T01:50:55.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a Show glossary option and updated metadata labels such as 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', along with capitalization tweaks to 'No FEAR Act Data' and a new site revision note 'Revision: v3.4.0'.
    Difference
    0.3%
    Check dated 2026-01-28T00:35:27.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:24:48.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    - The institution name was updated from UT Southwestern Medical Center to University of Texas Southwestern Medical Center.
    Difference
    0.1%
    Check dated 2025-12-30T08:41:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page.